» Articles » PMID: 36530915

Manual and Semi-automated Approaches to MIBG Myocardial Scintigraphy in Patients with Parkinson's Disease

Overview
Specialty General Medicine
Date 2022 Dec 19
PMID 36530915
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study investigates the effects of manual and semi-automatic methods for assessing MIBG semi-quantitative indices in a clinical setting.

Materials And Methods: We included I-MIBG scans obtained in 35 patients with idiopathic Parkinson's Disease. Early and late heart-to-mediastinum (H/M) ratios were calculated from I-MIBG images using regions of interest (ROIs) placed over the heart and the mediastinum. The ROIs were derived using two approaches: (i) manually drawn and (ii) semi-automatic fixed-size ROIs using anatomical landmarks. Expert, moderate-expert, and not expert raters applied the ROIs procedures and interpreted the I-MIBG images. We evaluated the inter and intra-rater agreements in assessing I-MIBG H/M ratios.

Results: A moderate agreement in the raters' classification of pathological and non-pathological scores emerged regarding early and late H/M ratio values (κ = 0.45 and 0.69 respectively), applying the manual method, while the early and late H/M ratios obtained with the semi-automatic method reached a good agreement among observers (κ = 0.78). Cohen-Kappa values revealed that the semi-automatic method improved the agreement between expert and inexpert raters: the agreement improved from a minimum of 0.29 (fair, for early H/M) and 0.69 (substantial, in late H/M) with the manual method, to 0.90 (perfect, in early H/M) and 0.87 (perfect, in late H/M) with the semi-automatic method.

Conclusion: The use of the semi-automatic method improves the agreement among raters in classifying' H/M ratios as pathological or non-pathological, namely for inexpert readers. These results have important implications for semi-quantitative assessment of I-MIBG images in clinical routine.

Citing Articles

Value of multi-parameter I-MIBG scintigraphy in the differential diagnosis of Parkinson's disease.

Xue T, Cui Y, Kan Y, Wang G, Yang J EJNMMI Res. 2025; 15(1):7.

PMID: 39875667 PMC: 11775374. DOI: 10.1186/s13550-025-01197-8.


Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.

Rissardo J, Caprara A Brain Sci. 2023; 13(10).

PMID: 37891838 PMC: 10605004. DOI: 10.3390/brainsci13101471.

References
1.
Knudsen K, Borghammer P . Imaging the Autonomic Nervous System in Parkinson's Disease. Curr Neurol Neurosci Rep. 2018; 18(11):79. DOI: 10.1007/s11910-018-0889-4. View

2.
McHugh M . Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012; 22(3):276-82. PMC: 3900052. View

3.
Nuvoli S, Spanu A, Fravolini M, Bianconi F, Cascianelli S, Madeddu G . [I]Metaiodobenzylguanidine (MIBG) Cardiac Scintigraphy and Automated Classification Techniques in Parkinsonian Disorders. Mol Imaging Biol. 2019; 22(3):703-710. DOI: 10.1007/s11307-019-01406-6. View

4.
Veltman C, Boogers M, Meinardi J, Al Younis I, Dibbets-Schneider P, van der Wall E . Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012; 39(10):1599-608. PMC: 3458210. DOI: 10.1007/s00259-012-2180-2. View

5.
Koo T, Li M . A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016; 15(2):155-63. PMC: 4913118. DOI: 10.1016/j.jcm.2016.02.012. View